HIF1A and age-related macular degeneration: Combining the results presented here with the results from the transplantation studies, genetic manipulation of human embryonic stem-derived RPE cells to express negative regulatory loops of HIF-1α could present a clinically feasible approach for future treatment of both dry and neovascular forms of AMD.